drugset / Trial / NCT06626464
A Study of Elpipodect (MK-8189) Human Absorption, Metabolism, and Excretion in Healthy Male Participants (MK-8189-010)
NaSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to learn what happens to elpipodect in a healthy person's body over time.
Timeline
- Start
- 2022-05-13
- Primary completion
- 2022-07-08
- Completion
- 2022-07-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-8189 | Small molecule | 4.5 mg | Oral |
Indications
No indication recorded.